Related Experiment Video
Updated: Apr 28, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
8.5K
Vascular soft-tissue sarcomas: a prognostic model from a retrospective single-center study
Kyoung Sook Park1, Hyo Song Kim, Yong Jin Cho
1Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Oncology
|June 14, 2014
Summary
Malignant vascular soft-tissue sarcomas, particularly angiosarcomas, are linked to poorer survival outcomes. Key prognostic factors include trunk location, older age, and incomplete tumor resection.
Area of Science:
- Oncology
- Surgical Pathology
- Vascular Tumors
Background:
- Vascular soft-tissue sarcomas are rare malignancies with diverse behaviors.
- Malignant subtypes require detailed clinicopathological characterization.
- Understanding survival outcomes is crucial for patient management.
Purpose of the Study:
- To describe the clinicopathological features of malignant vascular soft-tissue sarcomas.
- To identify prognostic factors influencing patient survival.
- To evaluate survival outcomes in relation to tumor characteristics and treatment.
Main Methods:
- Retrospective cohort study of 84 patients with vascular tumors.
- Histological examination for diagnosis.
- Overall survival (OS) as the primary endpoint.
- Multivariate analysis to identify independent prognostic factors.
Main Results:
- Angiosarcoma patients had significantly shorter overall survival (59.0 months) compared to other sarcoma subtypes (142.7 months).
- Independent prognostic factors for shorter survival included trunk primary site, age over 65, angiosarcoma pathology, and R2 resection.
- Bleeding episodes were more frequent in patients with poor survival outcomes.
Conclusions:
- Trunk location, angiosarcoma, and age over 65 are independent predictors of reduced survival.
- Complete surgical excision (R0 resection) is recommended for localized disease to improve survival.
- Frequent bleeding indicates a poorer prognosis in vascular soft-tissue sarcoma patients.
